Biomarkers as Intermediate End Points in Chemoprevention Trials

Scott M. Lippman(The University of Texas MD Anderson Cancer Center), J. S. Lee(Eisenhower Medical Center), Reuben Lotan(The University of Texas System), WN Hittelman(The University of Texas MD Anderson Cancer Center), Michael J. Wargovich(Eisenhower Medical Center), W. K. Hong(Eisenhower Medical Center)
JNCI Journal of the National Cancer Institute
April 4, 1990
10.1093/jnci/82.7.555
Cited by 186Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis